Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
12 December 2024 | Story André Damons | Photo André Damons
Dr Innocensia Mangoato
Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. Here she is with her supervisor and mentor Prof Motlalepula Matsabisa, Director of the University of the Free State (UFS) Department of Pharmacology.

A lecturer and researcher from the University of the Free State (UFS) Department of Pharmacology hopes her research into the use of cannabis in reversing anticancer drug resistance is a step forward into treating various cancers especially in Southern Africa.

Dr Innocensia Mangoato graduated on Tuesday (10 December 2024) with the degree Doctor of Philosophy with specialisation in pharmacology at the Faculty of Health Sciences’ December graduation ceremony. She started her career as a research scientist in the area of African traditional medicines in 2018 and her research received both national and international recognition.

“It’s an amazing (feeling to graduate today). My PhD journey was smooth and beautiful and with mentorship of Prof (Motlalepula) Matsabisa, who groomed me well, I did not shed a tear,” said Dr Mangoato. Dr Gudrun S Ulrich-Merzenich from the University of Bonn in Germany, was her co-supervisor with Prof Matsabisa.

According to the graduation programme, Dr Mangoato, Lecturer and Researcher in the UFS Department of Pharmacology, with her thesis titled Investigating the anticancer and possible resistant reversal effects of cannabis sativa l. extracts in cervical cancer cell lines and modulation of ABC transporters comprehensively explored the therapeutic potential of Cannabis sativa L. in overcoming drug resistance in cervical cancer using in vitro and network pharmacology approaches.

A step forward for treating various cancers

The research looked at the chemical fingerprints and pharmacological targets of C. sativa L. extracts, highlighting its antiproliferative properties against normal non-cancerous cells, cervical cancer cells and the cisplatin-resistant cervical cancer cells. Through PCR analysis, distinct gene expression profiles were identified, revealing the potential effects of combination treatments to counteract cisplatin resistance by downregulating genes associated with drug transporters and crucial signalling pathways. This work provides valuable insights into innovative therapeutic strategies for improving cervical cancer treatment, highlighting new avenues for overcoming resistance and enhancing treatment efficacy though the possible use of plant extracts.

“I hope my research takes a step forward in treating various cancers – especially gynaecology cancers in the Southern Hemisphere in Africa. Hopefully the research can later transcend into clinical trials and hopefully influence more policymakers. We also hope to further develop cannabis to be used as an adjuvant therapy for those drugs that are failing to treat cancer,” says Dr Mangoato, who was the recipient of the Women in Science Master’s Student in 2018.

Her graduation was also a proud moment for Prof Matsabisa, an expert in traditional African medicine, who was like a father to her during her studies. “Prof identified me from my honours degree and walked this journey with me. He has been a great mentor, a father and an amazing supervisor.”

Dr Mangoato says she will for now focus on research only and helping and monitoring upcoming researchers, especially female researchers as there is a scarcity of them her field. 

News Archive

Mekondjo! National exhibition to reveal the courage, determination, repression and torture of PLAN
2014-05-21

 
Angelina Angula ex PLAN soldier injured during the 1978 Cassinga attack - photo by John Liebenberg.

A pioneering exhibition by John Liebenberg and Christo Doherty is about to open on the Bloemfontein Campus. ‘Mekondjo! born in the struggle for Namibia’ gives South Africans their first insight into the lives of the men and women who fought against the SADF in the bush of Northern Namibia and Angola from 1966 – 1989.

This public exhibition presents eleven portraits of People’s Liberation Army veterans in the process of speaking about and coming to terms with their very different experiences in the Namibian War of Liberation.

When the People’s Liberation Army (PLAN) returned to Namibia after the UN-supervised elections of 1989, it had been fighting against South African rule for 23 years. Formed in 1966 as the armed wing of the South West African Peoples’ Organisation, PLAN had developed from a handful of poorly armed guerrillas to a sophisticated mechanised force. These soldiers fought alongside Angolan, Russian and Cuban soldiers against the SADF and UNITA. Since SWAPO’s election victory, the new government has mythologised the heroism of the armed struggle. The stories of the individual PLAN fighters’ experiences are only now being articulated, though.

Their stories are of great courage and determination against often impossible odds; but also of repression, torture, and disastrous decisions by the PLAN leadership.

The exhibition will be on display from Thursday 22 May to Friday 23 May for the duration of the Silence after Violence conference. The conference is hosted by the UFS Institute for Reconciliation and Social Justice and the Center for Holocaust Studies at the University of Vermont.

Date: Thursday 22 May and Friday 23 May 2014
Place: Centenary Complex, Reitz Hall, Bloemfontein Campus
Exhibition Introduction: Thursday 22 May, 14:00 – 15:30
Other viewing times: intermissions during the Silence after Violence programme

The public is welcome to attend.

* Spotlight photo: PLAN commissioner Nkrumah Mushelenga, Windhoek 2013 – photo by John Liebenberg

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept